Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 9, 2010, Pages 1562-1568

  Malik, Raza ^a   Lai, Michelle ^a   Sadiq, Amama ^a   Farnan, Rory ^a   Mehta, Shruti ^b   Nasser, Imad ^a   Challies, Tracy ^a   Schuppan, Detlef ^a   Afdhal, Nezam ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

fibroscan; fibrosis; liver biopsy; markers; non invasive

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOGRAPHY; ELASTOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 77956024417     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06371.x     Document Type: Article

References (25)

1. Friedman SL, Rockey DC, Bissell DM. Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Hepatology 2007 45 : 242 249.
2. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J. Gastroenterol. 1999 5 : 301 304.
3. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N. Engl. J. Med. 2001 344 : 495 500.
4. Stone MA, Mayberry JF. An audit of ultrasound guided liver biopsies: a need for evidence-based practice. Hepatogastroenterology 1996 43 : 432 434.
5. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am. J. Gastroenterol. 2004 99 : 1160 1174.
6. Leroy V, Monier F, Bottari S et al. Circulating MMP 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am. J. Gastroenterol. 2004 99 : 271 279.
7. Foucher J, Chanteloup E, Vergniol J et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006 55 : 403 408.
8. Lucidarme D, Foucher J, Le Bail B et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009 49 : 1083 1089.
9. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002 122 : 1620 1630.
10. Giannini E, Risso D, Botta F et al. Validity and clinical utility of the AST-ALT ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch. Intern. Med. 2003 163 : 218 224.
11. Ganne-Carrie N, Ziol M, de Ledinghen V et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006 44 : 1511 1517.
12. Kim SG, Kim YS, Jung SW et al. The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease. Korean J. Hepatol. 2009 15 : 42 51.
13. Halfon P, Bourliere M, Penaranda G et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp. Hepatol. 2005 11 : 4 6.
14. Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J. Viral. Hepat. 2007 14 : 107 115.
15. Chalasani N, Said A, Ness R, Hoen H, Lumeng L. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am. J. Gastroenterol. 1999 94 : 2224 2229.
16. Castéra L, Bail BL, Roudot-Thoraval F et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and noninvasive scores. J. Hepatol. 2009 50 : 59 68.
17. Bureau C, Metivier S, Peron JM et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment. Pharmacol. Ther. 2008 27 : 1261 1268.
18. Wai CT, Tan LH, Kaur M, Da CM, Quak SH, Tan KC. Pitfalls in interpreting liver biopsy results: the story of the blind men and the elephant. Liver Transpl. 2002 8 : 1200 1201.
19. Wang W, Beydoun MA. The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol. Rev. 2007 29 : 6 28.
20. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 1457.
21. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 2002 97 : 2614 2618.
22. Asselah T, Bieche I, Laurendeau I et al. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005 129 : 2064 2075.
23. Aggarwal K, Choe LH, Lee KH. Shotgun proteomics using the iTRAQ isobaric tags. Brief. Funct. Genomic. Proteomic. 2006 5 : 112 120.
24. Beljaars L, Molema G, Schuppan D et al. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor. J. Biol. Chem. 2000 275 : 12743 12751.
25. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999 29 : 664 669.